ArticleArchives of medical science : AMS2017
Neuropsychiatric symptoms and faster progression of cognitive impairments as predictors of risk of conversion of mild cognitive impairment to dementia.
Article in Archives of medical science : AMS, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Structural Neuroimaging Correlates of Neuropsychiatric Symptoms in Alzheimer's Disease: A Systematic Literature Review.Dementia and geriatric cognitive disorders · 2025Pooled it
- The Use of Mismatch Negativity in Conjunction with Neuropsychological Tests to Discriminate Alzheimer's Dementia, Mild Cognitive Impairment and Healthy Aging.Noro psikiyatri arsivi · 2025Article
- Aggressive behavior and prognosis in patients with mild cognitive impairment.Dementia & neuropsychologia · 2023Article
- A mild type of Nasu-Hakola disease - a case of a woman with presenile dementia and cystic bone lesions.Archives of medical science : AMS · 2023Article
- Somatic comorbidity and the progression of cognitive impairment.Frontiers in aging neuroscience · 2023Article
- Neuropsychiatric symptoms in patients with possible vascular cognitive impairment, does sex matter?Cerebral circulation - cognition and behavior · 2022Article
- A New Perspective on the Treatment of Alzheimer's Disease and Sleep Deprivation-Related Consequences: Can Curcumin Help?Oxidative medicine and cellular longevity · 2022Review
- Sirtuins, brain and cognition: A review of resveratrol effects.IBRO reports · 2020Article
- Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer's Patients Treated with Donepezil: Case Series.Neuropsychiatric disease and treatment · 2020Article
- Prediction of poor clinical outcome in vascular cognitive impairment: TRACE-VCI study.Alzheimer's & dementia (Amsterdam, Netherlands) · 2020Article
- Resveratrol and cognitive decline: a clinician perspective.Archives of medical science : AMS · 2019Article
- Neuropsychological comparison of incident MCI and prevalent MCI.Alzheimer's & dementia (Amsterdam, Netherlands) · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe aim of this research, based on 7 years of observations, was to assess the relationship between the dynamics of changes in the realm of cognitive functions in the early stages of observations and the presence of neuropsychiatric symptoms as well as further progression of cognitive function impairments in people diagnosed with mild cognitive impairment (MCI). MATERIAL AND
methodsOne hundred and ninety three individuals were included in the study, all of whom referred themselves to the Mental Health Clinic and were diagnosed with MCI based on the criteria of the Working Group on MCI. It was assumed that these individuals would be subjected to systematic psychiatric and neuropsychological observation until they were diagnosed with dementia. This report concerns a completed 7-year period of these observations. Participants were assessed based on the following scales: MMSE, NPI and GDS.
resultsThe obtained results indicate statistically significant differences between groups of subjects at the time of inclusion in the study, regarding the frequency of occurrence and severity of the following categories of impairments: thought impairments (
conclusionsThe accruing of cognitive function impairments and the presence of neuropsychiatric symptoms seem to be important risk factors for the development of dementia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.